Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 10:11:6365-6376.
doi: 10.2147/CMAR.S197544. eCollection 2019.

Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives

Affiliations

Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives

Jinyi Lang et al. Cancer Manag Res. .

Abstract

Nasopharyngeal carcinoma (NPC) is a rare type of head and neck cancer, with a higher incidence reported only in Southeast Asia and Northern Africa. Owing to the rarity of NPC occurrence, no internationally accepted consensus or guideline for its diagnosis and treatment is available. Based on the current evidences and practices, the Chinese experts on multidisciplinary diagnosis and treatment of NPC were designated to develop a national consensus for the treatment strategy of NPC. In this consensus, we report the development for improving the treatment efficacy and quality of life of NPC patients in China. The consensus also describes and recommends the role of multidisciplinary management approach in the management of NPC. A multidisciplinary team should include experts from different domains who can cater to the individualized needs of patients with NPC in a much more efficient manner. In addition, the team may also play a key role in developing guiding principles for future research, contributing to the improvement in the management of NPC.

Keywords: Asian; Chinese; consensus; nasopharyngeal carcinoma; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012: globocan 2012. Int J Cancer. 2015;136(5):E359–E386. doi: 10.1002/ijc.29210 - DOI - PubMed
    1. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol Off J Am Soc Clin Oncol. 1998;16(4):1310–1317. doi: 10.1200/JCO.1998.16.4.1310 - DOI - PubMed
    1. Tang -L-L, Chen W-Q, Xue W-Q, et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 2016;374(1):22–30. doi: 10.1016/j.canlet.2016.01.040 - DOI - PubMed
    1. Forman D, Bray F, Brewster DH, et al. Cancer incidence in five continents. International Association of Cancer Registries Scientific Publications. 2013;164.
    1. Ng WT, Yuen KT, Au KH, Chan OSH, Lee AWM. Staging of nasopharyngeal carcinoma–the past, the present and the future. Oral Oncol. 2014;50(6):549–554. doi: 10.1016/j.oraloncology.2013.06.003 - DOI - PubMed